Case 27 — Second Adulticide Treatment

Presenting Complaint

  • Heartworm treatment

Pertinent History

  • Marso presents to the Cardiology Service for the second step in treatment of his heartworm disease. Last month (11/13/99) Marso was diagnosed with heartworm disease and was given a single IM injection of melarsomine (100 mg). He is also microfilaria positive.
  • The owners report that Marso was lethargic and anorexic during the week following the injection. He also had intermittent episodes of difficulty breathing. His attitude subsequently improved; he is now breathing without apparent difficulty and his appetite is good. He is being kept indoors only, and the owners are restricting his activity. He has not had any more bleeding from his mouth, and his defecations are normal. The owners report that he still occasionally coughs at home, especially after drinking. He has always done this, and the owners think it is a sequela of his debarking surgery.

Physical Examination

  • General: BARH, Wt = 35.2 kg. T = 102.7°F; P = 104; R = panting (56 bpm with mouth closed).
  • Integument: Normal.
  • EENT: Normal.
  • Musculoskeletal: BCS = 4/9, no gait abnormalities.
  • Cardiovascular: CRT = 1 sec, mm pink. No murmurs. When Marso begins to pant his heart rate dramatically increases to ~180 bpm. No jugular pulses. Femoral pulses present bilaterally, no deficits.
  • Respiratory: Dog is breathing deeply.
  • GI: Normal.
  • GU: Normal.
  • Nervous system: Not examined.
  • Lymph nodes: WNL.

Clinical Diagnosis

  • Heartworm disease

Plans and Progress Notes

  • 12/16/99: Problem #1: Heartworm disease. S/O: Gave first dose of second stage of adulticide therapy — melarsomine (88 mg IM) in the left epaxial musculature along the L4 vertebra at 13:00H. This dose was lower than the dose given one month ago because the dog has lost weight. A: Adequate recovery following first stage of adulticide therapy. We have most likely killed the male worms at this point; the two injections in the second series will hopefully kill all the remaining worms. Risks associated with melarsomine treatment include direct lung toxicity, GI signs (vomiting), and later, pulmonary thromboembolism secondary to worm dissolution. P: Give second IM injection of melarsomine tomorrow afternoon.
  • 12/17/99: Problem #1: Heartworm disease. O: Marso’s resting respiratory rate ranges from 16–64 bpm. His heart rate is within normal limits (80–100 bpm), although he does have runs of tachycardia associated with an increase in his respiratory rate (when he begins panting). His temperature has remained within normal limits. He continues to be nervous and refuses to eat. He was given the second dose of melarsomine (88 mg IM) today at 13:00H within the right epaxial musculature at the level of L3. Approximately one hour later, he had a bout of diarrhea. A: The diarrhea may be due to his nervousness, or may be a reaction to the melarsomine. He is doing well otherwise. P: Continue to monitor vital signs.
  • 12/18/99: Problem #1: Heartworm disease. No change in Marso’s status. Discharged at 09:30H.

Discharge Instructions

  • We have given Marso his two remaining injections of melarsomine in the second step of treatment for his heartworm disease. He received one injection on each side of his back within the muscles. As a result, he may be sore in this area for the next week or so.
  • As you know, it is very important that Marso be kept indoors and quiet for the next month. Please do not allow him to rough-house with your other dog and only take him outside on a leash when he needs to go to the bathroom. Keeping him in a separate room or in a crate is ideal. Excitement or exercise can dislodge a large number of dead worms rather than allowing them to slowly decompose, and could cause serious problems, including death.
  • There is a possibility that Marso will experience some negative effects from the melarsomine itself and also as the remaining worms in his lungs are killed. Some of the side effects include difficulty breathing, lack of appetite, and gastrointestinal signs such as vomiting or diarrhea.
  • If he begins to have difficulty breathing or his respiratory rate at rest is rapid, please take him to your local veterinarian right away. If possible, check the rate of his breathing once daily when he is resting; if it is greater than 40 to 50 breaths per minute, call us or your local veterinarian.
  • Marso’s appetite may also be decreased during the next 7–10 days. If he begins to vomit or has diarrhea, please contact us or your local veterinarian. He may cough up a small amount of blood; if he continuously coughs or coughs up more than just a small amount, again, please contact us or your local veterinarian.
  • The treatments he has received do not kill the larvae present in his bloodstream. These are a potential reservoir for infection of mosquitoes, which can then spread the disease to other dogs. He can be treated with a heartworm preventative (Interceptor) in one month’s time to kill the circulating larvae. He must be observed at your local veterinarian for the day when he is given the Interceptor to ensure he does not have a bad reaction to the dying larvae.
  • Either your veterinarian or we can retest Marso in four months to check for any remaining adult heartworms by performing an antigen test. If he is still positive for adult heartworms, he may need another series of melarsomine injections.
  • Thank you for bringing Marso to the VMTH and entrusting his care in us. He is a beautiful boy and has a sweet disposition.

Quiz

1. Numerous other adverse effects, besides diarrhea, have been described as occurring within hours after melarsomine administration. Which of the following is one that has NOT been described?

2. Strict confinement or cage rest are recommended following heartworm adulticide therapy. Would it be a good idea to hospitalize this dog for several days immediately following the melarsomine administration in an attempt to prevent postadulticide complications due to worm embolization of the lungs?